CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K/A Event Exit or restructuring costs
- 8-K Event Exit or restructuring costs · Regulation FD disclosure
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K/A Event Executive or director change
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Regulation FD disclosure
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement · Results of operations · Executive or director change · Other events
- 8-K Event Material agreement · Other events
Page 1 of 24 · 467 filings